331 related articles for article (PubMed ID: 26724617)
1. The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation.
Karsy M; Guan J; Jensen R; Huang LE; Colman H
World Neurosurg; 2016 Apr; 88():222-236. PubMed ID: 26724617
[TBL] [Abstract][Full Text] [Related]
2. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
[TBL] [Abstract][Full Text] [Related]
3. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
5. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication.
Iwadate Y
Neurol Med Chir (Tokyo); 2018 Feb; 58(2):61-70. PubMed ID: 29129882
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma.
Iwadate Y; Matsutani T; Hirono S; Shinozaki N; Saeki N
J Neurooncol; 2016 Aug; 129(1):101-7. PubMed ID: 27193555
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications.
Yang L; Lin C; Wang L; Guo H; Wang X
Exp Cell Res; 2012 Nov; 318(19):2417-26. PubMed ID: 22906859
[TBL] [Abstract][Full Text] [Related]
9. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.
Dahan P; Martinez Gala J; Delmas C; Monferran S; Malric L; Zentkowski D; Lubrano V; Toulas C; Cohen-Jonathan Moyal E; Lemarie A
Cell Death Dis; 2014 Nov; 5(11):e1543. PubMed ID: 25429620
[TBL] [Abstract][Full Text] [Related]
10. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
[TBL] [Abstract][Full Text] [Related]
11. Oncogenesis recapitulates embryogenesis via the hypoxia pathway: morphoproteomics and biomedical analytics provide proof of concept and therapeutic options.
Brown RE; McGuire MF
Ann Clin Lab Sci; 2012; 42(3):243-57. PubMed ID: 22964612
[TBL] [Abstract][Full Text] [Related]
12. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.
Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB
Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258
[TBL] [Abstract][Full Text] [Related]
13. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
14. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha.
Seidel S; Garvalov BK; Wirta V; von Stechow L; Schänzer A; Meletis K; Wolter M; Sommerlad D; Henze AT; Nistér M; Reifenberger G; Lundeberg J; Frisén J; Acker T
Brain; 2010 Apr; 133(Pt 4):983-95. PubMed ID: 20375133
[TBL] [Abstract][Full Text] [Related]
15. Tropism of mesenchymal stem cell toward CD133
Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.
Wang Z; Zhang S; Siu TL; Huang S
Curr Pharm Des; 2015; 21(10):1268-71. PubMed ID: 25506897
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
18. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F
Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969
[TBL] [Abstract][Full Text] [Related]
19. Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.
Kling T; Ferrarese R; Ó hAilín D; Johansson P; Heiland DH; Dai F; Vasilikos I; Weyerbrock A; Jörnsten R; Carro MS; Nelander S
EBioMedicine; 2016 Oct; 12():72-85. PubMed ID: 27667176
[TBL] [Abstract][Full Text] [Related]
20. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
